Related Experiment Video
Updated: Aug 8, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer
A L DeVico1, T D Copeland, S Oroszlan
1Department of Cell Biology, Advanced BioScience Laboratories, Kensington, Maryland 20895.
Insights
A novel antibody (C2003) targeting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) was developed. This antibody inhibits viral polymerase activity by interfering with template binding.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a key enzyme for viral replication.
- Developing inhibitors targeting HIV-1 RT is crucial for antiviral therapy.
- Conserved regions in viral enzymes are potential targets for broadly active inhibitors.
Purpose of the Study:
- To generate and characterize a monospecific antibody against a conserved region of HIV-1 RT.
- To investigate the inhibitory mechanism of the antibody on viral reverse transcriptase activity.
- To explore the potential of this antibody as an antiviral agent.
Main Methods:
- Raised a rabbit monospecific antibody (C2003) against a synthetic peptide (CTP66) from HIV-1 RT p66.
- Assessed the antibody's inhibitory effect on the polymerase activity of HIV-1 RT and other retroviral RTs.
- Performed protection assays with template primer preincubation and kinetic studies (template primer concentration).
Main Results:
- The C2003 antibody directly inhibited the polymerase activity of HIV-1 RT and RTs from various retroviruses.
- Preincubation of HIV-1 RT with template primer protected the enzyme from antibody inhibition, an effect abrogated by high ionic strength.
- Kinetic studies revealed competitive inhibition with respect to template primer concentration, indicating interference with template binding.
Conclusions:
- The C2003 antibody effectively inhibits HIV-1 RT polymerase activity by interfering with template binding.
- The conserved residues recognized by C2003 are likely directly involved in the template binding function of HIV-1 RT.
- This antibody represents a potential tool for studying HIV-1 RT function and developing novel antiviral strategies.
Abstract:
We have raised a rabbit monospecific antibody (designated C2003) against a synthetic peptide (CTP66) derived from a conserved sequence in the C-terminal portion of the p66 component of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) (DeVico, A.L., Copeland, T.D., Veronese, F.D., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. (1989) AIDS Res. Hum. Retroviruses 5, 51-60). This antibody directly inhibits the polymerase activity of HIV-1 RT and of RTs from a variety of retroviruses. HIV-1 RT is protected from this inhibition by preincubation of the enzyme with template primer prior to treatment with the antibody. Such protection is abrogated when the pretreatment is conducted under conditions of high ionic strength. Kinetic studies showed that the antibody-mediated inhibition is competitive with respect to template primer concentration. These results indicate that C2003 antibody acts to interfere with the template binding function of the enzyme and further indicates that conserved residues recognized by the antibody may be directly involved in this function.
More Related Videos
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
13:07Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
Related Concept Videos
Retrovirus Life Cycles
Telomeres and Telomerase
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly